K Arnold Chan
Biographic Data
| ID | 5542746 |
|---|---|
| NAME | K Arnold Chan |
| GIVEN NAMES | K Arnold |
| FAMILY NAME | Chan |
| SIGNATURE | CHAN K A |
| AFFILIATIONS | Harvard University |
| ORCID | 0000-0001-8161-1986 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2009 |
| H-INDEX | 0 |
Active Influenza Vaccine Safety Surveillance
BACKGROUND: Rapid safety assessment of novel vaccines, especially those targeted against pandemic influenza, is a public health priority. OBJECTIVES: Assess the feasibility of using healthcare claims data to rapidly detect influenza vaccine adverse events using sequential analytic methods. RESEARCH DESIGN: Retrospective pilot study simulating prospective surveillance using 6 cumulative monthly administrative claims data extracts. The first includ…
Potential Drug–Drug Interactions in the Outpatient Setting
BACKGROUND: Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern. OBJECTIVE: We estimate the frequency of potentially interacting concomitant medication dispensing among outpatients. RESEARCH DESIGN: We report the number and percent of patients annually dispensed an object drug of interest (ie, warfarin, digoxin, cyclosporine, or lovastatin/simvastatin) with a potentiall…
No prominent works on this page.
Potential Drug–Drug Interactions in the Outpatient Setting
BACKGROUND: Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern. OBJECTIVE: We estimate the frequency of potentially interacting concomitant medication dispensing among outpatients. RESEARCH DESIGN: We report the number and percent of patients annually dispensed an object drug of interest (ie, warfarin, digoxin, cyclosporine, or lovastatin/simvastatin) with a potentiall…
Active Influenza Vaccine Safety Surveillance
BACKGROUND: Rapid safety assessment of novel vaccines, especially those targeted against pandemic influenza, is a public health priority. OBJECTIVES: Assess the feasibility of using healthcare claims data to rapidly detect influenza vaccine adverse events using sequential analytic methods. RESEARCH DESIGN: Retrospective pilot study simulating prospective surveillance using 6 cumulative monthly administrative claims data extracts. The first includ…
Medicine (2 works) · Pharmacovigilance and Adverse Drug Reactions (2 works) · Adverse effect (1 work) · Ambulatory care (1 work) · Antibody (1 work) · Atrial fibrillation (1 work) · Business (1 work) · Concomitant (1 work) · Confidence interval (1 work) · Data-Driven Disease Surveillance (1 work)